CIRculating CANcer MAster-Protocol (CIRCAN MAP)

Civil Hospices of Lyon

Status: Enrolling

Conditions: Adult With Solid Cancer

Treatments: Biological: Blood sampling for biomarker analysis (microRNA, circulating DNA…)

Study type: Observational

Funder types: Other

Identifiers

NCT05089747

69HCL21_0918

Details and patient eligibility

About

This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease

Enrollment: 6,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult (>18y)
• Owing a social security insurance
• Any solid cancer diagnosed by histopathology or cytology
• Patient with blood sampling required as per standard of care
• Informed consent signed

Exclusion criteria

• Refusal to participate
• No blood sampling required as per standard of care
• Hemoglobin < 7g/dl (< 9g/dl if respiratory or cardiovascular disease history)
• Heterologous blood transfusion in the last 48 hours
• Weight under 20 kg

Trial design

6,000 participants in 1 patient group

Adult with solid cancer. No intervention.

Treatment:

Biological: Blood sampling for biomarker analysis (microRNA, circulating DNA…)